NanJing Pharmaceutical Co Ltd (600713) — Net Asset Quality Index

Latest as of September 2025: 23.4%

NanJing Pharmaceutical Co Ltd (600713) has a Net Asset Quality Index of 23.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥34.05 Billion minus total liabilities of CN¥26.09 Billion yields net assets of CN¥7.95 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read NanJing Pharmaceutical Co Ltd (600713) total liabilities for a breakdown of total debt and financial obligations.

Quality Index

23.4%
Equity / Total Assets

Net Assets

CN¥7.95 Billion
CNY

Total Assets

CN¥34.05 Billion
CNY

Total Liabilities

CN¥26.09 Billion
CNY

NanJing Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1994–2024)

This chart shows how NanJing Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 31 annual periods from 1994 to 2024. As of September 2025, the index stands at 23.4%, representing net assets of CN¥7.95 Billion against total assets of CN¥34.05 Billion CNY. For live market cap and overall valuation, see 600713 market cap.

Annual Net Asset Quality Index for NanJing Pharmaceutical Co Ltd (1994–2024)

The table below presents the year-by-year Net Asset Quality Index for NanJing Pharmaceutical Co Ltd from 1994 to 2024, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of NanJing Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 25.4% CN¥7.79 Billion CN¥30.67 Billion CN¥22.89 Billion ▼ -0.1 pp
2023 25.5% CN¥7.25 Billion CN¥28.41 Billion CN¥21.16 Billion ▲ +4.4 pp
2022 21.2% CN¥6.69 Billion CN¥31.65 Billion CN¥24.96 Billion ▲ +0.9 pp
2021 20.2% CN¥5.23 Billion CN¥25.89 Billion CN¥20.65 Billion ▼ -0.4 pp
2020 20.6% CN¥4.82 Billion CN¥23.41 Billion CN¥18.59 Billion ▲ +0.0 pp
2019 20.6% CN¥4.52 Billion CN¥21.97 Billion CN¥17.45 Billion ▼ -0.4 pp
2018 21.0% CN¥4.11 Billion CN¥19.55 Billion CN¥15.45 Billion ▲ +1.0 pp
2017 20.0% CN¥3.19 Billion CN¥15.93 Billion CN¥12.74 Billion ▼ -2.0 pp
2016 22.0% CN¥3.07 Billion CN¥13.96 Billion CN¥10.89 Billion ▲ +0.7 pp
2015 21.3% CN¥2.69 Billion CN¥12.59 Billion CN¥9.91 Billion ▼ -0.1 pp
2014 21.5% CN¥2.44 Billion CN¥11.36 Billion CN¥8.92 Billion ▲ +8.1 pp
2013 13.3% CN¥1.29 Billion CN¥9.65 Billion CN¥8.36 Billion ▼ -0.9 pp
2012 14.2% CN¥1.31 Billion CN¥9.23 Billion CN¥7.91 Billion ▼ -0.8 pp
2011 15.0% CN¥1.36 Billion CN¥9.02 Billion CN¥7.67 Billion ▼ 0.0 pp
2010 15.1% CN¥1.26 Billion CN¥8.37 Billion CN¥7.11 Billion ▲ +3.7 pp
2009 11.4% CN¥744.78 Million CN¥6.52 Billion CN¥5.77 Billion ▼ -0.7 pp
2008 12.1% CN¥610.69 Million CN¥5.04 Billion CN¥4.43 Billion ▼ -1.9 pp
2007 14.0% CN¥700.93 Million CN¥5.00 Billion CN¥4.30 Billion ▼ -3.4 pp
2006 17.5% CN¥643.97 Million CN¥3.69 Billion CN¥3.04 Billion ▼ -2.0 pp
2005 19.4% CN¥646.94 Million CN¥3.33 Billion CN¥2.68 Billion ▼ -0.2 pp
2004 19.6% CN¥614.14 Million CN¥3.13 Billion CN¥2.52 Billion ▼ -3.7 pp
2003 23.3% CN¥611.84 Million CN¥2.63 Billion CN¥2.02 Billion ▼ -4.6 pp
2002 27.8% CN¥505.29 Million CN¥1.82 Billion CN¥1.31 Billion ▼ -12.5 pp
2001 40.3% CN¥472.04 Million CN¥1.17 Billion CN¥697.93 Million ▲ +0.7 pp
2000 39.6% CN¥486.93 Million CN¥1.23 Billion CN¥742.31 Million ▼ -7.4 pp
1999 47.0% CN¥444.61 Million CN¥946.18 Million CN¥501.56 Million ▼ -2.2 pp
1998 49.2% CN¥426.92 Million CN¥867.23 Million CN¥440.31 Million ▼ -5.2 pp
1997 54.5% CN¥250.94 Million CN¥460.74 Million CN¥209.80 Million ▲ +5.5 pp
1996 48.9% CN¥212.84 Million CN¥435.11 Million CN¥222.28 Million ▲ +18.8 pp
1995 30.1% CN¥82.01 Million CN¥272.12 Million CN¥190.11 Million ▼ -2.9 pp
1994 33.1% CN¥87.17 Million CN¥263.64 Million CN¥176.47 Million
pp = percentage points